Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers
Nguemeni Tiako M, Afranie-Sakyi J, Van Doren L, Vasquez K, Calhoun C. Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers. Blood 2024, 144: 2442-2442. DOI: 10.1182/blood-2024-206368.Peer-Reviewed Original ResearchSickle cell diseaseChronic painOpioid analgesicsSide effectsX-waiverPain managementAdequate analgesiaRespiratory depressionTraditional opioidsOff-labelSickle cell disease providerBuprenorphine formulationsImproving provider knowledgeFDA approvalSurvey of providersRisk of respiratory depressionCross-sectional surveyEffective opioid analgesicMedical education opportunitiesOpioid-induced hyperalgesiaSickle cell disease patientsCompared to other opioidsMorphine milligram equivalentsOpioid side effectsAbuse-deterrent technology